JPRN-UMIN000016058
Recruiting
未知
Clinical trial of lumbar fusion in combination with platelet rich plasma(PRP) and allograft. - Clinical trial of lumbar fusion in combination with PRP and allograft.
Graduate school of medicine chiba univresity0 sites34 target enrollmentDecember 26, 2014
Conditionslumbar stenosis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- lumbar stenosis
- Sponsor
- Graduate school of medicine chiba univresity
- Enrollment
- 34
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. severe systemic complication for example, heart failure,renal failure, liver failure, respiratory failure 2\.anamnesis of AMI and cardiac hypofunction 3\.complication of severe angina 4\.severe renal function failure 5\..severe lever function failure 6\.respiratory functional failure 7\.diabetes more than HbA1c9\.0 8\.psycological complication 9\.pregnancy 10\.hypersensitivity for thrombin 11\.cardiac stimulation medication hypercalcemia 12\.inadequate patients 13\.disturbance of consciousness
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A randomized controlled trial of lumbar fusion in combination with platelet-rich plasma(PRP)JPRN-UMIN000011501Chiba University Hospital160
Completed
Not Applicable
umbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group.Chronic Low Back PainMusculoskeletal - Other muscular and skeletal disordersACTRN12615000162516Sahlgrenska University Hospital294
Recruiting
Phase 2
A randomized controlled trial of the lumbar-type of HAL for the safety and efficacy in hemiplegic patients with acute strokeCerebral infarction and cerebral hemorrhage patients with hemiplegia and sit-to-stand disorderCerebral infarction, Cerebral hemorrhageJPRN-jRCTs032230039Matsumaru Yuji44
Recruiting
Not Applicable
A clinical study on safety and efficacy of combined intraarterial cisplatin and 5-fluorouracil with systemic pegylated interferon alfa-2b for advanced hepatocellular carcinomaJPRN-UMIN000009107Iwate Medical University60
Active, not recruiting
Phase 1
Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients.EUCTR2018-003300-39-ESFundación para la Investigación Biomédica de Córdoba150